USD 65.32
(-3.27%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 111.19 Million USD | 5.54% |
2022 | 105.35 Million USD | 28.96% |
2021 | 81.69 Million USD | 34.36% |
2020 | 60.8 Million USD | 26.24% |
2019 | 48.16 Million USD | 18.91% |
2018 | 40.5 Million USD | 7.36% |
2017 | 37.72 Million USD | 44.09% |
2016 | 26.18 Million USD | 95.59% |
2015 | 13.38 Million USD | 78.07% |
2014 | 7.51 Million USD | 113.7% |
2013 | 3.51 Million USD | 25.2% |
2012 | 2.81 Million USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 125.44 Million USD | 10.2% |
2024 Q1 | 113.83 Million USD | 2.38% |
2023 Q4 | 111.19 Million USD | 4.32% |
2023 Q3 | 106.59 Million USD | 2.17% |
2023 FY | 111.19 Million USD | 5.54% |
2023 Q1 | 103.65 Million USD | -1.61% |
2023 Q2 | 104.32 Million USD | 0.65% |
2022 Q3 | 95.89 Million USD | 3.62% |
2022 FY | 105.35 Million USD | 28.96% |
2022 Q1 | 83.15 Million USD | 1.79% |
2022 Q2 | 92.54 Million USD | 11.29% |
2022 Q4 | 105.35 Million USD | 9.87% |
2021 Q4 | 81.69 Million USD | 32.44% |
2021 FY | 81.69 Million USD | 34.36% |
2021 Q3 | 61.68 Million USD | -8.8% |
2021 Q2 | 67.63 Million USD | 12.86% |
2021 Q1 | 59.92 Million USD | -1.44% |
2020 Q2 | 52.56 Million USD | -0.64% |
2020 Q4 | 60.8 Million USD | 2.72% |
2020 Q3 | 59.19 Million USD | 12.62% |
2020 FY | 60.8 Million USD | 26.24% |
2020 Q1 | 52.9 Million USD | 9.84% |
2019 Q4 | 48.16 Million USD | 4.31% |
2019 FY | 48.16 Million USD | 18.91% |
2019 Q2 | 45.29 Million USD | 7.77% |
2019 Q1 | 42.03 Million USD | 3.78% |
2019 Q3 | 46.17 Million USD | 1.94% |
2018 Q2 | 37.75 Million USD | 10.1% |
2018 FY | 40.5 Million USD | 7.36% |
2018 Q4 | 40.5 Million USD | 1.24% |
2018 Q3 | 40 Million USD | 5.96% |
2018 Q1 | 34.29 Million USD | -9.1% |
2017 FY | 37.72 Million USD | 44.09% |
2017 Q4 | 37.72 Million USD | -1.95% |
2017 Q3 | 38.47 Million USD | -9.05% |
2017 Q2 | 42.3 Million USD | -7.81% |
2017 Q1 | 45.89 Million USD | 75.28% |
2016 Q4 | 26.18 Million USD | -7.35% |
2016 Q2 | 25.05 Million USD | 79.95% |
2016 FY | 26.18 Million USD | 95.59% |
2016 Q1 | 13.92 Million USD | 4.0% |
2016 Q3 | 28.26 Million USD | 12.81% |
2015 FY | 13.38 Million USD | 78.07% |
2015 Q1 | 10.73 Million USD | 42.82% |
2015 Q4 | 13.38 Million USD | -2.58% |
2015 Q3 | 13.74 Million USD | 8.19% |
2015 Q2 | 12.7 Million USD | 18.29% |
2014 Q2 | 5.91 Million USD | 16.15% |
2014 Q4 | 7.51 Million USD | 2.34% |
2014 Q3 | 7.34 Million USD | 24.26% |
2014 Q1 | 5.09 Million USD | 44.68% |
2014 FY | 7.51 Million USD | 113.7% |
2013 Q3 | 2.8 Million USD | 8.68% |
2013 Q1 | 3.03 Million USD | 8.09% |
2013 Q4 | 3.51 Million USD | 25.23% |
2013 FY | 3.51 Million USD | 25.2% |
2013 Q2 | 2.58 Million USD | -14.9% |
2012 Q4 | 2.81 Million USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | 2.81 Million USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1998 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | -2221.878% |
Safety Shot Inc | 1.86 Million USD | -5847.433% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 26.893% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -1542.724% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | -243.919% |
Dynavax Technologies Corporation | 53.29 Million USD | -108.662% |
Esperion Therapeutics, Inc. | 65.62 Million USD | -69.447% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | -854.718% |
Pacira BioSciences, Inc. | 104.35 Million USD | -6.558% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -1838.984% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -1838.984% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -13632.021% |
Journey Medical Corporation | 10.2 Million USD | -989.516% |
Alpha Teknova, Inc. | 11.59 Million USD | -859.082% |
Procaps Group, S.A. | 96.83 Million USD | -14.833% |
Theratechnologies Inc. | 6.06 Million USD | -1733.103% |
Harrow Health, Inc. | 10.86 Million USD | -923.245% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -3989.592% |
Biofrontera Inc. | 10.9 Million USD | -919.399% |
DURECT Corporation | 2.21 Million USD | -4911.086% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -43.649% |
Cronos Group Inc. | 30.33 Million USD | -266.512% |
OptiNose, Inc. | 8.05 Million USD | -1280.974% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -11119599900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -1851.138% |
Organogenesis Holdings Inc. | 28.25 Million USD | -293.572% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -4053.58% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -2312.395% |
Radius Health, Inc. | 278.64 Million USD | 60.094% |
Universe Pharmaceuticals INC | 3.34 Million USD | -3225.969% |
ProPhase Labs, Inc. | 3.84 Million USD | -2794.975% |
Phibro Animal Health Corporation | 265.91 Million USD | 58.183% |
Procaps Group S.A. | 96.83 Million USD | -14.833% |
Alvotech | 74.43 Million USD | -49.391% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 96.795% |
Rockwell Medical, Inc. | 5.87 Million USD | -1793.987% |
Aytu BioPharma, Inc. | 12.63 Million USD | -780.203% |
SIGA Technologies, Inc. | 64.21 Million USD | -73.153% |
Tilray Brands, Inc. | 252.08 Million USD | 55.89% |
Lifecore Biomedical, Inc. | 39.97 Million USD | -178.136% |
Shineco, Inc. | 1.58 Million USD | -6899.953% |
PetIQ, Inc. | 159.3 Million USD | 30.201% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 72882.73% |
Incannex Healthcare Limited | -10.01 Million USD | 1210.295% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | -190.329% |
Alimera Sciences, Inc. | 1.87 Million USD | -5817.829% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | -195.059% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -6804.907% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -2380.393% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -43617.368% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -971.252% |
Hempacco Co., Inc. | 2.54 Million USD | -4273.27% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | -49.391% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -132.657% |
Lantheus Holdings, Inc. | 64.02 Million USD | -73.665% |
Currenc Group, Inc. | 732.91 Thousand USD | -15071.829% |
Kamada Ltd. | 87.74 Million USD | -26.724% |
Indivior PLC | 141.79 Million USD | 21.582% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -22977.37% |
Flora Growth Corp. | 8.5 Million USD | -1206.958% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -43617.368% |
Evolus, Inc. | 10.99 Million USD | -911.057% |
HUTCHMED (China) Limited | 50.25 Million USD | -121.25% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | -5.067% |
Akanda Corp. | 1.28 Million USD | -8540.65% |